Patients on first-line treatment, who had experienced VTE, showed a trend towards a worse prognosis than patients on second, third or fourth line of chemotherapy; however, this was not statistically significant ( P =0.28).
1
—
—
Patients on first-line treatment, who had experienced VTE, showed a trend towards a worse prognosis than patients on second, third or fourth line of chemotherapy; however, this was not statistically significant ( P =0.28).